Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $261,501 | 215 | 57.6% |
| Consulting Fee | $111,945 | 89 | 24.6% |
| Travel and Lodging | $46,146 | 173 | 10.2% |
| Food and Beverage | $32,714 | 1,074 | 7.2% |
| Honoraria | $1,380 | 2 | 0.3% |
| Education | $519.80 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $107,226 | 270 | $0 (2024) |
| Janssen Biotech, Inc. | $50,986 | 164 | $0 (2024) |
| UCB, Inc. | $40,101 | 106 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $34,430 | 123 | $0 (2024) |
| ABBVIE INC. | $29,597 | 200 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $29,265 | 105 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $26,458 | 73 | $0 (2024) |
| GENZYME CORPORATION | $23,979 | 52 | $0 (2024) |
| Galderma Laboratories, L.P. | $22,137 | 43 | $0 (2024) |
| Dermavant Sciences, Inc. | $21,055 | 83 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $170,397 | 528 | Lilly USA, LLC ($29,615) |
| 2023 | $162,267 | 475 | Lilly USA, LLC ($36,693) |
| 2022 | $83,469 | 344 | Lilly USA, LLC ($27,119) |
| 2021 | $38,073 | 217 | Lilly USA, LLC ($13,798) |
All Payment Transactions
1,564 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Travel and Lodging | Cash or cash equivalent | $29.88 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $1,115.70 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $75.60 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.68 | General |
| Category: Immunology | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $4,182.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,314 | 2,587 | $232,356 | $69,396 |
| 2022 | 11 | 1,198 | 2,213 | $214,168 | $65,044 |
| 2021 | 8 | 1,007 | 1,879 | $176,104 | $55,192 |
| 2020 | 10 | 1,185 | 2,260 | $188,781 | $58,110 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 491 | 681 | $105,569 | $31,007 | 29.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 257 | 372 | $41,437 | $11,679 | 28.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 102 | 109 | $18,976 | $6,412 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 82 | $18,153 | $5,155 | 28.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 207 | 1,151 | $12,431 | $4,272 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 71 | 71 | $13,646 | $3,684 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $5,745 | $1,741 | 30.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 44 | $4,234 | $1,520 | 35.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $4,226 | $1,390 | 32.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 15 | $3,756 | $1,194 | 31.8% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $2,938 | $893.71 | 30.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 14 | $1,244 | $447.84 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 434 | 587 | $91,123 | $27,091 | 29.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 216 | 296 | $32,971 | $9,209 | 27.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 116 | 124 | $21,587 | $7,227 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 95 | $20,842 | $6,799 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 77 | 77 | $14,793 | $4,200 | 28.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 174 | 915 | $9,882 | $3,459 | 35.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 28 | $7,815 | $3,061 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,472 | $1,546 | 20.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 17 | $3,231 | $951.76 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 26 | $2,497 | $771.33 | 30.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 16 | 22 | $1,955 | $727.67 | 37.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 428 | 608 | $94,762 | $29,284 | 30.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 186 | 250 | $27,887 | $8,178 | 29.3% |
About Leigh Pansch, NP
Leigh Pansch, NP is a Family healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1104138601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leigh Pansch, NP has received a total of $454,205 in payments from pharmaceutical and medical device companies, with $170,397 received in 2024. These payments were reported across 1,564 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($261,501).
As a Medicare-enrolled provider, Pansch has provided services to 4,704 Medicare beneficiaries, totaling 8,939 services with total Medicare billing of $247,742. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Dayton, OH
- Active Since 07/13/2010
- Last Updated 08/03/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1104138601
Products in Payments
- TREMFYA (Drug) $59,559
- DUPIXENT (Biological) $48,633
- TALTZ (Drug) $44,692
- Sotyktu (Drug) $29,515
- RINVOQ (Biological) $24,814
- OLUMIANT (Drug) $23,806
- Bimzelx (Biological) $20,515
- VTAMA (Drug) $16,930
- AKLIEF (Drug) $14,979
- Cimzia (Drug) $9,514
- SPEVIGO (Drug) $9,355
- Zoryve (Drug) $8,560
- CIBINQO (Drug) $5,940
- Olumiant (Drug) $4,649
- YCANTH (Drug) $4,445
- TAPINAROF (Drug) $4,125
- COSENTYX (Biological) $4,031
- SKYRIZI (Biological) $3,205
- TWYNEO (Drug) $2,544
- COSENTYX (Drug) $2,269
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Dayton
Nafresha Abuaun, Pmhnp-Bc, Fnp-Bc, PMHNP-BC, FNP-BC
Family — Payments: $10,047
Mrs. Elissa Reed, Fnp-C, FNP-C
Family — Payments: $9,791
Mrs. Caitlyn Frantz, Np-C, NP-C
Family — Payments: $8,564
Dilfuza Makhmudova
Family — Payments: $6,762
Jacqueline Papalios, Fnp-C, FNP-C
Family — Payments: $6,254
Mrs. Anna Schubert
Family — Payments: $5,857